Two more medical centers in the US have chosen the anti-blood clotting devices developed MCS Medical Compression Systems (DBN) Ltd. (TASE:MDCL). A medical center in Arkansas and another in Indiana have chosen the company's ActiveCare +SFT device for the treatment of deep vein thrombosis following orthopedic surgery. The company did not disclose the size of the deals.
MCS said that the two medical centers carry out about 2,800 relevant procedures a year, and it estimates that its device will be used in a quarter of them, about 700 patients, in the first year.
MCS CEO Adi Dagan said, "As we expected, our penetration rate at US medical centers is accelerating. We believe that doctors now prefer using our ActiveCare +SFT device over medication. Interest in our solution is growing, and we believe that we will sell to more medical centers in the coming months.
MCS's share price fell 3.3% by mid-afternoon today to NIS 3.42, giving a market cap of NIS 129 million.
Published by Globes [online], Israel business news - www.globes-online.com - on May 5, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010